London, United Kingdom

Allen Hanburys Limited


USPTO Granted Patents = 41

Trademarks = 1

Forward Citations = 1,260

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Gwynn Pennant Ellis (6 out of 6 patents)

silverMedal Ian Collins (6 out of 6 patents)

bronzeMedal Barry J Price (6 out of 28 patents)

4.  Alexander W Oxford (5 out of 58 patents)

5.  John Bradshaw (5 out of 40 patents)

6.  Mervyn Evan Peel (5 out of 5 patents)

7.  David Edmund Bays (5 out of 5 patents)

8.  Lawrence Henry Lunts (5 out of 5 patents)

9.  David Hartley (4 out of 10 patents)

10.  John W Clitherow (4 out of 40 patents)

11.  David Martin Waters (4 out of 4 patents)

12.  David Trevor Collin (4 out of 4 patents)

13.  Stanley M Roberts (4 out of 4 patents)

14.  Michael James (3 out of 3 patents)

15.  Norman James Harper (2 out of 2 patents)


Core Competencies:
Aerosol Steroids
Furan Derivatives
Pharmacologically Active Compounds
Phenylethanolamine
Isoquinolium Compounds
Tetrazole Derivatives
Prostaglandin Intermediates
Chromone Derivatives
Pharmaceutical Compositions
Spasmogen Inhibition
Cyclopent Indene Compounds

41 patents:

Allen Hanburys Limited, based in London, specializes in the development and manufacture of advanced pharmaceutical formulations, particularly micronized aerosol steroids and pharmacologically active compounds. The company focuses on innovative therapeutic agents, including aminoalkyl furan derivatives and isoquinolium compounds, aimed at enhancing drug delivery and efficacy. Their expertise extends to creating devices for dispensing medicaments and formulating steroidal aerosol compositions, contributing significantly to the field of respiratory and systemic therapies.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

41 Patents

#101 in London

#431 in United Kingdom

#16,686 in the World

London, GB
London, United Kingdom
Forward Citations = 1,260

35 inventors:

Please report any incorrect information to [email protected]
Loading…